药明康德：子公司上海药明拟以28亿元出售医疗资产

Core Viewpoint - WuXi AppTec announced that its wholly-owned subsidiary, Shanghai WuXi, plans to transfer 100% equity stakes in Shanghai Kande Hongyi Medical Clinical Research Co., Ltd. and Shanghai WuXi Jinshi Pharmaceutical Technology Co., Ltd. to Shanghai Shihe Rong Enterprise Management Consulting Co., Ltd. and Shanghai Shihe Mu Enterprise Management Consulting Co., Ltd. for a consideration of RMB 2.8 billion [1] Group 1 - The transaction involves the transfer of two companies under WuXi AppTec's portfolio [1] - The total consideration for the equity transfer is set at RMB 2.8 billion [1]